The construction industry is looking at steady growth this year due to banks making more loans and bonds available for the industry’s market. Also, there will be a more balanced growth in the construction industry in 2015, according to Dodge Data & Analytics. The company is projecting that commercial building will improve 15%, compared to the 14% gain in 2014. Institutional building will increase 9%. Here are some of the best building products companies TheStreet Quant Ratings says you should consider looking at. Number 3 is Caesarstone Sdot-Yam. With an 'A-' rating, the company's strengths can be seen in its revenue growth and increase in net income. 2nd is, Apogee Enterprises. This rating is an 'A+.' Apogee thrives in its solid stock price performance and compelling growth in net income. Number 1 is A. O. Smith Corporation. With an 'A+' rating the company flourishes in its revenue growth and notable return on equity. TheStreet Ratings are algorithmic stock picks based on 32 major data points. S&P 500 stocks rated 'buy' yielded a 16.5% return in 2014, beating the S&P 500 Total Return Index by more than 300 basis points. For the full reports on these stocks, you can check out TheStreet.com/QuantRatings.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.